Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma

Ukihide Tateishi, Masahiko Kusumoto, Hiroshi Nishihara, Kazuo Nagashima, Toshiaki Morikawa, Noriyuki Moriyama

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

BACKGROUND. The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement. METHODS. Dynamic CT scans were evaluated retrospectively in 130 patients with primary lung carcinoma who did not have distant metastasis and who underwent surgical resection with mediastinal lymph node dissection. Histopathologic findings of vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) were correlated with the maximum attenuation values of time-attenuation curves (MAV) on dynamic CT scans. RESULTS. The MAV in VEGF positive tumors was greater compared with the MAV in VEGF negative tumors (66.1 ± 4.6 vs. 30.9 ± 2.7, respectively; P < 0.0001). An association was found between the MAV in VEGF positive tumors and MVD (correlation coefficient = 0.650; P < 0.0001). No difference was found in tumor size with pathologic confirmation and the MAV, VEGF expression, or MVD. The MAV, VEGF expression, and MVD in lung tumors with lymph node involvement were greater compared with the same values in lung tumors without lymph node involvement. CONCLUSIONS. The MAV of dynamic CT may be a predictor of tumor angiogenesis in patients with lung carcinoma and lymph node involvement.

Original languageEnglish
Pages (from-to)835-842
Number of pages8
JournalCancer
Volume95
Issue number4
DOIs
Publication statusPublished - 2002 Aug 15
Externally publishedYes

Fingerprint

Tomography
Carcinoma
Lung
Vascular Endothelial Growth Factor A
Microvessels
Neoplasms
Lymph Nodes
Lymph Node Excision
Neoplasm Metastasis

Keywords

  • Angiogenesis
  • Computed tomography
  • Lung
  • Lung carcinoma
  • Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. / Tateishi, Ukihide; Kusumoto, Masahiko; Nishihara, Hiroshi; Nagashima, Kazuo; Morikawa, Toshiaki; Moriyama, Noriyuki.

In: Cancer, Vol. 95, No. 4, 15.08.2002, p. 835-842.

Research output: Contribution to journalArticle

Tateishi, Ukihide ; Kusumoto, Masahiko ; Nishihara, Hiroshi ; Nagashima, Kazuo ; Morikawa, Toshiaki ; Moriyama, Noriyuki. / Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. In: Cancer. 2002 ; Vol. 95, No. 4. pp. 835-842.
@article{43819de1f35a4b16b27147b513f80bb8,
title = "Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma",
abstract = "BACKGROUND. The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement. METHODS. Dynamic CT scans were evaluated retrospectively in 130 patients with primary lung carcinoma who did not have distant metastasis and who underwent surgical resection with mediastinal lymph node dissection. Histopathologic findings of vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) were correlated with the maximum attenuation values of time-attenuation curves (MAV) on dynamic CT scans. RESULTS. The MAV in VEGF positive tumors was greater compared with the MAV in VEGF negative tumors (66.1 ± 4.6 vs. 30.9 ± 2.7, respectively; P < 0.0001). An association was found between the MAV in VEGF positive tumors and MVD (correlation coefficient = 0.650; P < 0.0001). No difference was found in tumor size with pathologic confirmation and the MAV, VEGF expression, or MVD. The MAV, VEGF expression, and MVD in lung tumors with lymph node involvement were greater compared with the same values in lung tumors without lymph node involvement. CONCLUSIONS. The MAV of dynamic CT may be a predictor of tumor angiogenesis in patients with lung carcinoma and lymph node involvement.",
keywords = "Angiogenesis, Computed tomography, Lung, Lung carcinoma, Neoplasms",
author = "Ukihide Tateishi and Masahiko Kusumoto and Hiroshi Nishihara and Kazuo Nagashima and Toshiaki Morikawa and Noriyuki Moriyama",
year = "2002",
month = "8",
day = "15",
doi = "10.1002/cncr.10730",
language = "English",
volume = "95",
pages = "835--842",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma

AU - Tateishi, Ukihide

AU - Kusumoto, Masahiko

AU - Nishihara, Hiroshi

AU - Nagashima, Kazuo

AU - Morikawa, Toshiaki

AU - Moriyama, Noriyuki

PY - 2002/8/15

Y1 - 2002/8/15

N2 - BACKGROUND. The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement. METHODS. Dynamic CT scans were evaluated retrospectively in 130 patients with primary lung carcinoma who did not have distant metastasis and who underwent surgical resection with mediastinal lymph node dissection. Histopathologic findings of vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) were correlated with the maximum attenuation values of time-attenuation curves (MAV) on dynamic CT scans. RESULTS. The MAV in VEGF positive tumors was greater compared with the MAV in VEGF negative tumors (66.1 ± 4.6 vs. 30.9 ± 2.7, respectively; P < 0.0001). An association was found between the MAV in VEGF positive tumors and MVD (correlation coefficient = 0.650; P < 0.0001). No difference was found in tumor size with pathologic confirmation and the MAV, VEGF expression, or MVD. The MAV, VEGF expression, and MVD in lung tumors with lymph node involvement were greater compared with the same values in lung tumors without lymph node involvement. CONCLUSIONS. The MAV of dynamic CT may be a predictor of tumor angiogenesis in patients with lung carcinoma and lymph node involvement.

AB - BACKGROUND. The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement. METHODS. Dynamic CT scans were evaluated retrospectively in 130 patients with primary lung carcinoma who did not have distant metastasis and who underwent surgical resection with mediastinal lymph node dissection. Histopathologic findings of vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) were correlated with the maximum attenuation values of time-attenuation curves (MAV) on dynamic CT scans. RESULTS. The MAV in VEGF positive tumors was greater compared with the MAV in VEGF negative tumors (66.1 ± 4.6 vs. 30.9 ± 2.7, respectively; P < 0.0001). An association was found between the MAV in VEGF positive tumors and MVD (correlation coefficient = 0.650; P < 0.0001). No difference was found in tumor size with pathologic confirmation and the MAV, VEGF expression, or MVD. The MAV, VEGF expression, and MVD in lung tumors with lymph node involvement were greater compared with the same values in lung tumors without lymph node involvement. CONCLUSIONS. The MAV of dynamic CT may be a predictor of tumor angiogenesis in patients with lung carcinoma and lymph node involvement.

KW - Angiogenesis

KW - Computed tomography

KW - Lung

KW - Lung carcinoma

KW - Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0037103024&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037103024&partnerID=8YFLogxK

U2 - 10.1002/cncr.10730

DO - 10.1002/cncr.10730

M3 - Article

C2 - 12209728

AN - SCOPUS:0037103024

VL - 95

SP - 835

EP - 842

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -